-
公开(公告)号:US06890947B2
公开(公告)日:2005-05-10
申请号:US10659664
申请日:2003-09-10
申请人: Alfred Binggeli , Beat Wirz , Uwe Grether , Hans Hilpert , Roland Humm , Hans Iding , Bernd Kuhn , Hans-Peter Maerki , Markus Meyer , Peter Mohr
发明人: Alfred Binggeli , Beat Wirz , Uwe Grether , Hans Hilpert , Roland Humm , Hans Iding , Bernd Kuhn , Hans-Peter Maerki , Markus Meyer , Peter Mohr
IPC分类号: A61K31/405 , A61P3/06 , A61P3/10 , A61P9/10 , C07D413/06 , C07D413/14 , C07D417/06 , A61K31/404 , C07D209/04
CPC分类号: C07D413/06 , C07D417/06
摘要: Compounds of formula I are provided as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R8, A, A1 and n have the significance indicated in the specification.
摘要翻译: 提供了式I化合物及其药学上可接受的盐和酯,其中R 1至R 8,A,A 1和N 2 具有说明书中指出的意义。
-
公开(公告)号:US06420166B2
公开(公告)日:2002-07-16
申请号:US09834129
申请日:2001-04-12
申请人: Hans Iding , Mark Rogers-Evans , Beat Wirz
发明人: Hans Iding , Mark Rogers-Evans , Beat Wirz
IPC分类号: C12P1320
CPC分类号: C12P41/007 , C12P13/20 , C12P17/10
摘要: The present invention provides a process for the preparation of D-asparagine derivatives of formula I wherein R1 is an amino protecting group and R2 is an alkyl, a substituted alkyl or a group of formula A R3(OCH2CH2)n— A wherein R3 is hydrogen or an lower alkyl group and n is 1, 2 or 3, which process comprises reacting a compound of formula II wherein R1 and R2 are as defined above, with a protease in an aqueous solution at a pH of 6.0-7.5 and an organic solvent, and subsequently extracting the enantiomeric pure product of formula I. Compounds of formula I can be used as intermediates in the production of antibacterial substances.
摘要翻译: 本发明提供了制备式I的D-天冬酰胺衍生物的方法,其中R1是氨基保护基,R2是烷基,取代的烷基或式A的基团,其中R3是氢或低级烷基,n是1 ,2或3,该方法包括使R1和R2如上所定义的式II化合物与蛋白酶在pH为6.0-7.5的水溶液和有机溶剂中反应,随后萃取式对映体纯的产物 I.式I化合物可用作生产抗菌物质的中间体。
-
公开(公告)号:US07820699B2
公开(公告)日:2010-10-26
申请号:US11403973
申请日:2006-04-13
申请人: Katrin Groebke Zbinden , Wolfgang Haap , Hans Hilpert , Narendra Panday , Fabienne Ricklin , Beat Wirz
发明人: Katrin Groebke Zbinden , Wolfgang Haap , Hans Hilpert , Narendra Panday , Fabienne Ricklin , Beat Wirz
IPC分类号: A61K31/4436 , A61K31/4439 , C07D409/14 , C07D401/14
CPC分类号: C07D207/12 , C07D207/14 , C07D207/16 , C07D401/14 , C07D409/14 , C07D413/14 , C07D513/04
摘要: The invention is concerned with cyclic amines of formula (I) wherein X1 to X3, Y1 to Y3, R1′, R1″ and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit coagulation factor Xa and can be used as medicaments and for treating diseases associated with coagulation factor Xa.
摘要翻译: 本发明涉及式(I)的环胺,其中X1至X3,Y1至Y3,R1',R1“和n如说明书和权利要求书中所定义,以及其生理学上可接受的盐。 这些化合物抑制凝血因子Xa,可用作药物和治疗与凝血因子Xa相关的疾病。
-
公开(公告)号:US5283346A
公开(公告)日:1994-02-01
申请号:US990231
申请日:1992-12-14
申请人: Richard Barner , Josepf Hubscher , Beat Wirz
发明人: Richard Barner , Josepf Hubscher , Beat Wirz
IPC分类号: C07D317/20 , C07D317/24 , C07D317/72 , C12P17/04 , C12P41/00 , C07D317/18
CPC分类号: C07D317/72 , C07D317/20 , C07D317/24 , C12P17/04 , C12P41/004
摘要: Alcohols of the formula ##STR1## wherein R.sup.1 and R.sup.2 are each independently methyl or ethyl or together signify pentamethylene, formed by the enzymatic hydrolysis of a corresponding (RS) alkanoic acid ester are intermediates for Vitamin E.
摘要翻译: 式(Ib)的醇其中R 1和R 2各自独立地是甲基或乙基或一起表示通过相应的(RS)链烷酸酯的酶水解形成的五亚甲基酯是维生素E的中间体。
-
公开(公告)号:US5232852A
公开(公告)日:1993-08-03
申请号:US492166
申请日:1990-03-13
申请人: Richard Barner , Josepf Hubscher , Beat Wirz
发明人: Richard Barner , Josepf Hubscher , Beat Wirz
IPC分类号: C07D311/72 , C07D317/18 , C07D317/20 , C07D317/24 , C07D317/72 , C12P17/04 , C12P41/00
CPC分类号: C07D317/72 , C07D317/20 , C07D317/24 , C12P17/04 , C12P41/004
摘要: Alcohols of the formula ##STR1## wherein R.sup.1 and R.sup.2 are each independently methyl or ethyl or together signify pentamethylene,formed by the enzymatic hydrolysis of a corresponding (RS) alkanoic acid ester are intermediates for Vitamin E.
摘要翻译: 式(Ib)的醇其中R 1和R 2各自独立地是甲基或乙基,或一起表示通过相应的(RS)链烷酸酯的酶水解形成的五亚甲基酯是维生素E的中间体。
-
公开(公告)号:US5902738A
公开(公告)日:1999-05-11
申请号:US829280
申请日:1997-03-31
申请人: Bernard Orsat , Paul Spurr , Beat Wirz
发明人: Bernard Orsat , Paul Spurr , Beat Wirz
IPC分类号: C12N9/20 , C07C35/18 , C12P7/40 , C12P7/62 , C12P7/64 , C12P23/00 , C12P7/02 , C07C67/02 , C12N11/02
摘要: A process for making a compound of formula ##STR1## wherein R signifies a C.sub.1-23 -alkyl group or a C.sub.2-23 -alkenyl group containing 1 to 3 double bonds, comprising the steps of (a) reacting a compound of formula ##STR2## with an acylating agent which is in a mixture comprising (i) an organic solvent and (ii) a lipase which is present in suspension, so as to form the compound of formula I; and (b) recovering the compound of formula I is provided for. The process can be used to make (11Z,13Z)-7,10-dihydro-10-hydroxy-retinyl acetate, an starting material for the production of vitamin A acetate.
摘要翻译: 一种制备下式化合物的方法,其中R表示C1-23-烷基或含1〜3个双键的C2-23链烯基,包括以下步骤:(a)使式的化合物与酰化剂反应, 是在(i)有机溶剂和(ii)存在于悬浮液中的脂肪酶的混合物中,以形成式I化合物; 和(b)回收式I化合物。 该方法可用于制备(11Z,13Z)-7,10-二氢-10-羟基 - 视黄基乙酸酯,一种生产维生素A乙酸酯的原料。
-
公开(公告)号:US5532232A
公开(公告)日:1996-07-02
申请号:US343168
申请日:1994-11-22
申请人: Jean Ackermann , David Banner , Klaus Gubernator , Paul Hadvary , Kurt Hilpert , Klaus Muller , Ludvik Labler , Gerard Schmid , Thomas B. Tschopp , Hans P. Wessel , Beat Wirz
发明人: Jean Ackermann , David Banner , Klaus Gubernator , Paul Hadvary , Kurt Hilpert , Klaus Muller , Ludvik Labler , Gerard Schmid , Thomas B. Tschopp , Hans P. Wessel , Beat Wirz
IPC分类号: A61K31/445 , A61K31/4427 , A61K31/4433 , A61K31/47 , A61K31/535 , A61K31/5375 , A61K31/55 , A61P7/02 , A61P35/00 , C07D20060101 , C07D211/20 , C07D211/22 , C07D211/26 , C07D211/60 , C07D265/30 , C07D265/32 , C07D401/12 , C07D401/14 , C07D409/12 , C07D409/14 , C07D413/12
CPC分类号: C07D265/30 , C07D211/22 , C07D211/26 , C07D211/60 , C07D265/32 , C07D401/12 , C07D401/14 , C07D409/12 , C07D409/14 , C07D413/10 , C07D413/12 , Y10S514/822
摘要: Compounds of the formula ##STR1## wherein L, M, R, T and X are set forth in the description, as well as hydrates or solvates thereof, which inhibit thrombin-induced platelet aggregation and clotting of fibrinogen in plasma, are described. The compounds of formula I are prepared by amidination or, depending on whether L is NH or O, by amide formation or esterification.
-
公开(公告)号:US5393760A
公开(公告)日:1995-02-28
申请号:US77476
申请日:1993-06-15
申请人: Jean Ackermann , David Banner , Klaus Gubernator , Paul Hadvary , Kurt Hilpert , Klaus Muller , Ludvik Labler , Gerard Schmid , Thomas B. Tschopp , Hans P. Wessel , Beat Wirz
发明人: Jean Ackermann , David Banner , Klaus Gubernator , Paul Hadvary , Kurt Hilpert , Klaus Muller , Ludvik Labler , Gerard Schmid , Thomas B. Tschopp , Hans P. Wessel , Beat Wirz
IPC分类号: A61K31/445 , A61K31/4427 , A61K31/4433 , A61K31/47 , A61K31/535 , A61K31/5375 , A61K31/55 , A61P7/02 , A61P35/00 , C07D20060101 , C07D211/20 , C07D211/22 , C07D211/26 , C07D211/60 , C07D265/30 , C07D265/32 , C07D401/12 , C07D401/14 , C07D409/12 , C07D409/14 , C07D413/12
CPC分类号: C07D265/30 , C07D211/22 , C07D211/26 , C07D211/60 , C07D265/32 , C07D401/12 , C07D401/14 , C07D409/12 , C07D409/14 , C07D413/10 , C07D413/12 , Y10S514/822
摘要: Compounds of the formula ##STR1## wherein L, M, R, T and X are set forth in the description, as well as hydrates or solvates thereof, which inhibit thrombin-induced platelet aggregation and clotting of fibrinogen in plasma, are described. The compounds of formula I are prepared by amidination or, depending on whether L is NH or O, by amide formation or esterification.
摘要翻译: 描述了其描述中描述的L,M,R,T和X以及其中抑制凝血酶诱导的血小板聚集和血浆中纤维蛋白原凝血的水合物或溶剂化物的式ⅠA化合物。 式I的化合物通过酰胺化或通过酰胺形成或酯化作用取决于L是NH或O来制备。
-
公开(公告)号:US5595999A
公开(公告)日:1997-01-21
申请号:US473060
申请日:1995-06-07
申请人: Jean Ackermann , David Banner , Klaus Gubernator , Paul Hadvary , Kurt Hilpert , Klaus M uller , Ludvik Labler , G erard Schmid , Thomas B. Tschopp , Hans P. Wessel , Beat Wirz
发明人: Jean Ackermann , David Banner , Klaus Gubernator , Paul Hadvary , Kurt Hilpert , Klaus M uller , Ludvik Labler , G erard Schmid , Thomas B. Tschopp , Hans P. Wessel , Beat Wirz
IPC分类号: A61K31/445 , A61K31/4427 , A61K31/4433 , A61K31/47 , A61K31/535 , A61K31/5375 , A61K31/55 , A61P7/02 , A61P35/00 , C07D20060101 , C07D211/20 , C07D211/22 , C07D211/26 , C07D211/60 , C07D265/30 , C07D265/32 , C07D401/12 , C07D401/14 , C07D409/12 , C07D409/14 , C07D413/12
CPC分类号: C07D265/30 , C07D211/22 , C07D211/26 , C07D211/60 , C07D265/32 , C07D401/12 , C07D401/14 , C07D409/12 , C07D409/14 , C07D413/10 , C07D413/12 , Y10S514/822
摘要: Compounds of the formula ##STR1## wherein L, M, R, T and X are set forth in the description, as well as hydrates or solvates thereof, which inhibit thrombin-induced platelet aggregation and clotting of fibrinogen in plasma, are described. The compounds of formula I are prepared by amidination or, depending on whether L is NH or O, by amide formation or esterification.
摘要翻译: 描述了其描述中描述的L,M,R,T和X以及其中抑制凝血酶诱导的血小板聚集和血浆中纤维蛋白原凝血的水合物或溶剂化物的式ⅠA化合物。 式I的化合物通过酰胺化或通过酰胺形成或酯化作用取决于L是NH或O来制备。
-
公开(公告)号:US06437142B1
公开(公告)日:2002-08-20
申请号:US09817465
申请日:2001-03-26
申请人: Hans Hilpert , Beat Wirz
发明人: Hans Hilpert , Beat Wirz
IPC分类号: C07D27762
CPC分类号: C12P7/62 , C07B2200/07 , C07C45/29 , C07C45/69 , C07C69/013 , C07C403/08 , C07C2601/14 , C07F7/1804 , C07F7/188 , Y02P20/55 , Y02P20/582 , C07C47/273 , C07C49/175
摘要: A new process prepares retiferol derivatives of formula I: wherein A is —C≡C— or —CH═CH—, and R1 and R2 are independently of each other lower alkyl or lower perfluoroalkyl, one version couples ketones of formula II with compounds of formula III. A second version couples phosphinoxides of formula IV with aldehydes of formula V. Compounds of formula I are useful in the treatment or prevention of hyperproliferative skin diseases and for reversing the conditions associated with photodamage.
摘要翻译: 新方法制备式I的复方酮衍生物:其中A是-C = C-或-CH = CH-,并且R 1和R 2彼此独立地为低级烷基或低级全氟烷基,一种形式将式Ⅱ化合物与式III化合物 。 第二个版本将式IV的膦氧基与式V的醛结合。式I化合物可用于治疗或预防过度增生性皮肤疾病并且用于逆转与光损伤相关的病症。
-
-
-
-
-
-
-
-
-